Breathing breakthrough? drug tested to keep obese patients safer during lung surgery
NCT ID NCT04583046
Summary
This study tested whether a drug called iloprost, inhaled during surgery, could improve oxygen levels in the blood of obese patients undergoing lung cancer surgery. During this type of surgery, one lung is temporarily taken 'offline' for the operation, which can make it harder for the body to get enough oxygen. The researchers wanted to see if iloprost, which relaxes blood vessels in the lungs, could help prevent this dangerous drop in oxygen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (INCLUDING METASTATIC CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Severance Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.